PRQR logo

ProQR Therapeutics NV (PRQR) Company Overview

Profile

Full Name:

ProQR Therapeutics N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Netherlands

IPO:

September 18, 2014

Indexes:

Not included

Website:

http://www.proqr.com

Description:

ProQR Therapeutics NV is a biotechnology company focused on developing RNA-based therapies for genetic diseases. They aim to treat conditions caused by mutations in genes, using innovative approaches to create targeted treatments that can improve patients' lives. Their research emphasizes precision medicine and advancing genetic therapies.

Key Details

Price

$1.97

Market Cap

$208.64 M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$7.05 M(+86.06% YoY)

Annual EPS

-$0.38(+60.08% YoY)

PE Ratio

-

Annual ROE

-51.92%

Annual Debt To Equity

0.10

Beta

1.26

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Mar 13, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 12, 25 Jones Trading
Buy
Dec 12, 24 JMP Securities
Market Outperform
Dec 12, 24 HC Wainwright & Co.
Buy
Dec 12, 24 Chardan Capital
Buy
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 29, 24 Raymond James
Strong Buy
May 10, 24 HC Wainwright & Co.
Buy
May 10, 24 Chardan Capital
Buy
Apr 18, 24 Citigroup
Neutral
Mar 14, 24 HC Wainwright & Co.
Buy

Screeners with PRQR included

Growing Shares Outstanding
Stocks with high beta
Stocks below SMA 200
Healthcare sector
All stocks
NASDAQ Listed Companies
Biotechnology industry
Small cap stocks
Earnings next week
NASDAQ earnings calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$1.97
PRQR price is $1.97

Price All-time High

$24.99
PRQR price is currently -92.12% below its historical high of $24.99

Price Analysts Target

-
PRQR price consensus analysts' forecast is unknown

Price Most Recent Change

+1.55%
PRQR price was up +1.55% on Mar 7, 2025

Price YTD Change

-25.66%
PRQR price is down -25.66% since January 1st

Price 3-Year Change

+111.83%
PRQR price is up +111.83% over the past 3 years

Market cap

Market Cap

$208.64 M
PRQR market capitalization is $208.64 million

Market Cap 3-Year Change

+214.68%
PRQR market capitalization is up +214.68% over the past 3 years

Market Cap All-time High

$867.23 M
PRQR market capitalization is currently -75.94% below its historical high of $867.23 million

Market Cap Sector Rank

56.05%
PRQR market capitalization is higher than 56.05% of companies in Healthcare sector

Technical

Beta

1.26
PRQR beta is 1.26

200-day SMA

$2.38
PRQR price is currently -17.19% below its 200-day simple moving average

14-day RSI

32.76
PRQR 14-day relative strength index is 32.76

30-day Relative Volume

1.10
PRQR 30-day relative volume is 1.10

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$7.05 M
PRQR annual revenue is $7.05 million

Annual Revenue Analysts Estimate

$21.92 M
PRQR annual revenue is currently -67.82% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+86.06%
PRQR annual revenue is up +86.06% year-on-year

Annual Revenue Sector Rank

28.52%
PRQR annual revenue is higher than 28.52% of companies in Healthcare sector

Profit

Annual Gross Profit

-
PRQR annual gross profit value is unknown

Annual Gross Margin

-
PRQR annual gross profit margin value is unknown

Annual Operating Profit

-$37.66 M
PRQR annual operating income is -$37.66 million

Annual Operating Margin

-534.08%
PRQR annual operating profit margin is -534.08%

Annual Net Income

-$30.44 M
PRQR annual net profit is -$30.44 million

Annual Net Margin

-431.67%
PRQR annual net profit margin is -431.67%

EPS

Annual EPS

-$0.38
PRQR annual earnings per share is -$0.38

Annual EPS Analysts Estimate

-$0.48
PRQR annual earnings per share is currently -21.39% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+60.08%
PRQR annual earnings per share is up +60.08% year-on-year

Annual EPS Sector Rank

71.88%
PRQR annual earnings per share is higher than 71.88% of companies in Healthcare sector

ROA & ROE

Annual ROA

-18.11%
PRQR annual return on assets is -18.11%

Annual ROE

-51.92%
PRQR annual return on equity is -51.92%

EBIT & EBITDA

Annual EBIT

-$28.81 M
PRQR annual earnings before interest & taxes is -$28.81 million

Annual EBITDA

-$26.09 M
PRQR annual EBITDA is -$26.09 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
PRQR price to earnings ratio value is unknown

PE Ratio Sector Rank

-
PRQR price to earnings ratio is unknown

PB Ratio

PB Ratio

7.48
PRQR price to book ratio is 7.48

PB Ratio Sector Rank

88.47%
PRQR price to book ratio is higher than 88.47% of companies in Healthcare sector

PS Ratio

PS Ratio

10.76
PRQR price to sales ratio is 10.76

PS Ratio Sector Rank

78.88%
PRQR price to sales ratio is higher than 78.88% of companies in Healthcare sector

Enterprise value

Enterprise Value

$128.22 M
PRQR enterprise value is $128.22 million

Enterprise Value Sector Rank

50.87%
PRQR enterprise value is higher than 50.87% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-6.23
PRQR EV/EBITDA is -6.23

EV/EBITDA Sector Rank

19.44%
PRQR EV/EBITDA is higher than 19.44% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.54
PRQR annual current ratio is 3.54

Annual Quick Ratio

-
PRQR annual quick ratio value is unknown

Leverage

Annual Debt To Equity

0.10
PRQR annual debt to equity ratio is 0.10

Annual Interest Coverage Ratio

-22.12
PRQR annual interest coverage ratio is -22.12

Risk & Stability

Piotroski F-Score

-
PRQR piotroski f-score value is unknown

Altman Z-Score

-2.72
PRQR altman z-score is -2.72

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$152.42 M
PRQR annual total assets is $152.42 million

Annual Non Current Assets

$18.68 M
PRQR annual long term assets is $18.68 million

Annual Current Assets

$133.74 M
PRQR annual total current assets is $133.74 million

Annual Cash & Cash Equivalents

$131.46 M
PRQR annual cash & cash equivalents is $131.46 million

Equity

Annual Book Value

$45.75 M
PRQR annual book value is $45.75 million

Annual Working Capital

$95.93 M
PRQR annual working capital is $95.93 million

Liabilities

Annual Total Liabilities

$106.66 M
PRQR annual total liabilities is $106.66 million

Annual Total Long Term Liabilities

$68.86 M
PRQR annual total long term liabilities is $68.86 million

Annual Current Liabilities

$37.81 M
PRQR annual total current liabilities is $37.81 million

Annual Accounts Payable

$1.70 M
PRQR annual accounts payable is $1.70 million

Debt

Annual Total Debt

$21.81 M
PRQR annual total debt is $21.81 million

Annual Total Debt 1-Year Change

-7.42%
PRQR annual total debt is down -7.42% year-on-year

Annual Long Term Debt

$20.03 M
PRQR annual long term debt is $20.03 million

Annual Short Term Debt

$1.78 M
PRQR annual short term debt is $1.78 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$44.72 M
PRQR annual total expenses is $44.72 million

Annual Operating Expenses

$44.72 M
PRQR annual total operating expenses is $44.72 million

Annual Cost Of Goods Sold

-
PRQR annual cost of goods sold value is unknown

Annual SGA

$17.58 M
PRQR annual SGA is $17.58 million

Annual D&A

$2.72 M
PRQR annual depreciation & amortization is $2.72 million

Annual Interest Expense

$1.30 M
PRQR annual interest expense is $1.30 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$23.33 M
PRQR annual cash flow from operations is $23.33 million

Annual CFO 1-Year Change

+132.29%
PRQR annual cash flow from operations is up +132.29% year-on-year

Annual CFI

$4.63 M
PRQR annual cash flow from investing activities is $4.63 million

Annual CFI 1-Year Change

+725.61%
PRQR annual cash flow from investing activities is up +725.61% year-on-year

Annual CFF

-$2.46 M
PRQR annual cash flow from financing activities is -$2.46 million

Annual CFF 1-Year Change

+92.44%
PRQR annual cash flow from financing activities is up +92.44% year-on-year

Free CashFlow

Annual FCF

$21.84 M
PRQR annual free cash flow is $21.84 million

Annual FCF 1-Year Change

+129.93%
PRQR annual free cash flow is up +129.93% year-on-year

CAPEX

Annual CAPEX

$1.48 M
PRQR annual capital expenditures is $1.48 million

Annual CAPEX 1-Year Change

+98.78%
PRQR annual capital expenditures is up +98.78% year-on-year

Institutional Ownership

Similar stocks

SGMO logo
Sangamo Therapeutics (SGMO)
INGN logo
Inogen (INGN)
KRRO logo
Korro Bio (KRRO)
LYEL logo
Lyell Immunopharma (LYEL)
TVGN logo
Tevogen Bio Holdings (TVGN)
PROF logo
Profound Medical (PROF)
Zhengye Biotechnology Holding Limited (ZYBT)
LFMD logo
LifeMD (LFMD)
LRMR logo
Larimar Therapeutics (LRMR)

FAQ

  • What is the ticker symbol for ProQR Therapeutics NV?
  • Does ProQR Therapeutics NV pay dividends?
  • What sector is ProQR Therapeutics NV in?
  • What industry is ProQR Therapeutics NV in?
  • What country is ProQR Therapeutics NV based in?
  • When did ProQR Therapeutics NV go public?
  • Is ProQR Therapeutics NV in the S&P 500?
  • Is ProQR Therapeutics NV in the NASDAQ 100?
  • Is ProQR Therapeutics NV in the Dow Jones?
  • When was ProQR Therapeutics NV's last earnings report?
  • When does ProQR Therapeutics NV report earnings?

What is the ticker symbol for ProQR Therapeutics NV?

The ticker symbol for ProQR Therapeutics NV is NASDAQ:PRQR

Does ProQR Therapeutics NV pay dividends?

No, ProQR Therapeutics NV does not pay dividends

What sector is ProQR Therapeutics NV in?

ProQR Therapeutics NV is in the Healthcare sector

What industry is ProQR Therapeutics NV in?

ProQR Therapeutics NV is in the Biotechnology industry

What country is ProQR Therapeutics NV based in?

ProQR Therapeutics NV is headquartered in Netherlands

When did ProQR Therapeutics NV go public?

ProQR Therapeutics NV's initial public offering (IPO) was on September 18, 2014

Is ProQR Therapeutics NV in the S&P 500?

No, ProQR Therapeutics NV is not included in the S&P 500 index

Is ProQR Therapeutics NV in the NASDAQ 100?

No, ProQR Therapeutics NV is not included in the NASDAQ 100 index

Is ProQR Therapeutics NV in the Dow Jones?

No, ProQR Therapeutics NV is not included in the Dow Jones index

When was ProQR Therapeutics NV's last earnings report?

ProQR Therapeutics NV's most recent earnings report was on Nov 7, 2024

When does ProQR Therapeutics NV report earnings?

The next expected earnings date for ProQR Therapeutics NV is Mar 13, 2025